Success Metrics

Active Trials
8(100%)

Phase Distribution

Ph not_applicable
1
13%
Ph phase_2
2
25%
Ph phase_3
4
50%
Ph phase_1
1
13%

Phase Distribution

1

Early Stage

2

Mid Stage

4

Late Stage

Phase Distribution8 total trials
Phase 1Safety & dosage
1(12.5%)
Phase 2Efficacy & side effects
2(25.0%)
Phase 3Large-scale testing
4(50.0%)
N/ANon-phased studies
1(12.5%)

Highest Phase Reached

Phase 3

Trial Status & Enrollment

Completion Rate

0.0%

0 of 0 finished

Non-Completion Rate

0.0%

0 ended early

Currently Active

8

trials recruiting

Total Trials

8

all time

Status Distribution
Active(8)

Detailed Status

Active, not recruiting5
Recruiting3

Development Timeline

Analytics

Development Status

Total Trials
8
Active
8
Success Rate
N/A
Most Advanced
Phase 3

Trials by Phase

Phase 11 (12.5%)
Phase 22 (25.0%)
Phase 34 (50.0%)
N/A1 (12.5%)

Trials by Status

recruiting338%
active_not_recruiting563%

Recent Activity

Clinical Trials (8)

Drug Details

Intervention Type
RADIATION
Total Trials
8